Temelimab versus placebo in patients with post-COVID condition

Mayssam Nehme, Margret Hund-Georgiadis, Esther Del Corral Beamonte, Pierre-Olivier Bridevaux, Robert Hoepner, Iris-Katharina Penner, Joana Strobel, Gregory Fretz, Mercè Boada Rovira, Francesc Puchades, Francesco Landi, Pablo Guisado Vasco, Giovanni Guaraldi, Francisco Mera Cordero, Luca Sebastianelli, Loredana Sarmati, Nathalie Berthuy, Jérôme Wojcik, Karim Keddad, Anke Post, David Leppert, Idris Guessous

Open source

DOI: 10.1016/j.bbi.2026.106892
Published: 2026-11
Container: Brain, Behavior, and Immunity
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bbi.2026.106892,
  title = {Temelimab versus placebo in patients with post-COVID condition},
  author = {Mayssam Nehme and Margret Hund-Georgiadis and Esther Del Corral Beamonte and Pierre-Olivier Bridevaux and Robert Hoepner and Iris-Katharina Penner and Joana Strobel and Gregory Fretz and Mercè Boada Rovira and Francesc Puchades and Francesco Landi and Pablo Guisado Vasco and Giovanni Guaraldi and Francisco Mera Cordero and Luca Sebastianelli and Loredana Sarmati and Nathalie Berthuy and Jérôme Wojcik and Karim Keddad and Anke Post and David Leppert and Idris Guessous},
  year = {2026},
  journal = {Brain, Behavior, and Immunity},
  doi = {10.1016/j.bbi.2026.106892},
  url = {https://doi.org/10.1016/j.bbi.2026.106892}
}

RIS

TY  - JOUR
TI  - Temelimab versus placebo in patients with post-COVID condition
AU  - Mayssam Nehme
AU  - Margret Hund-Georgiadis
AU  - Esther Del Corral Beamonte
AU  - Pierre-Olivier Bridevaux
AU  - Robert Hoepner
AU  - Iris-Katharina Penner
AU  - Joana Strobel
AU  - Gregory Fretz
AU  - Mercè Boada Rovira
AU  - Francesc Puchades
AU  - Francesco Landi
AU  - Pablo Guisado Vasco
AU  - Giovanni Guaraldi
AU  - Francisco Mera Cordero
AU  - Luca Sebastianelli
AU  - Loredana Sarmati
AU  - Nathalie Berthuy
AU  - Jérôme Wojcik
AU  - Karim Keddad
AU  - Anke Post
AU  - David Leppert
AU  - Idris Guessous
PY  - 2026
JO  - Brain, Behavior, and Immunity
DO  - 10.1016/j.bbi.2026.106892
UR  - https://doi.org/10.1016/j.bbi.2026.106892
ER  -

APA

Nehme, M., Hund-Georgiadis, M., Beamonte, E. D. C., Bridevaux, P., Hoepner, R., Penner, I., Strobel, J., Fretz, G., Rovira, M. B., Puchades, F., Landi, F., Vasco, P. G., Guaraldi, G., Cordero, F. M., Sebastianelli, L., Sarmati, L., Berthuy, N., Wojcik, J., Keddad, K., Post, A., Leppert, D., & Guessous, I. (2026). Temelimab versus placebo in patients with post-COVID condition. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2026.106892

Source records

crossref · retrieved 2026-09-26T21:21:00.394Z